LQB-861,,,,,,
Peso Molecular,347.326,,Absorption,Water solubility,-5.383,Numeric (log mol/L)
LogP,4.5135,,Absorption,Caco2 permeability,0.386,Numeric (log Papp in 10-6 cm/s)
Nº de Ligações Rotativas,3,,Absorption,Intestinal absorption (human),93.845,Numeric (% Absorbed)
Nº de Aceptores de Hidrogênio,5,,Absorption,Skin Permeability,-2.664,Numeric (log Kp)
Nº de Doadores de Hidrogênio,0,,Absorption,P-glycoprotein substrate,Yes,Categorical (Yes/No)
Área de Superfície Molecular,148.032,,Absorption,P-glycoprotein I inhibitor,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein II inhibitor,Yes,Categorical (Yes/No)
,,,Distribution,VDss (human),0.124,Numeric (log L/kg)
,,,Distribution,Fraction unbound (human),0.044,Numeric (Fu)
,,,Distribution,BBB permeability,-0.521,Numeric (log BB)
,,,Distribution,CNS permeability,-1.677,Numeric (log PS)
,,,Metabolism,CYP2D6 substrate,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 substrate,Yes,Categorical (Yes/No)
,,,Metabolism,CYP1A2 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C19 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C9 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2D6 inhibitior,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 inhibitior,Yes,Categorical (Yes/No)
,,,Excretion,Total Clearance,0.215,Numeric (log ml/min/kg)
,,,Excretion,Renal OCT2 substrate,No,Categorical (Yes/No)
,,,Toxicity,AMES toxicity,Yes,Categorical (Yes/No)
,,,Toxicity,Max. tolerated dose (human),-0.272,Numeric (log mg/kg/day)
,,,Toxicity,hERG I inhibitor,No,Categorical (Yes/No)
,,,Toxicity,hERG II inhibitor,Yes,Categorical (Yes/No)
,,,Toxicity,Oral Rat Acute Toxicity (LD50),2.82,Numeric (mol/kg)
,,,Toxicity,Oral Rat Chronic Toxicity (LOAEL),1.399,Numeric (log mg/kg_bw/day)
,,,Toxicity,Hepatotoxicity,No,Categorical (Yes/No)
,,,Toxicity,Skin Sensitisation,No,Categorical (Yes/No)
,,,Toxicity,T.Pyriformis toxicity,0.707,Numeric (log ug/L)
,,,Toxicity,Minnow toxicity,-1.666,Numeric (log mM)
,,,,,,
,,,,,,
,,,,,,
,,,Absorption,Water solubility,-5.383,Numeric (log mol/L)
,,,Absorption,Caco2 permeability,0.386,Numeric (log Papp in 10-6 cm/s)
,,,Absorption,Intestinal absorption (human),93.845,Numeric (% Absorbed)
,,,Absorption,Skin Permeability,-2.664,Numeric (log Kp)
,,,Absorption,P-glycoprotein substrate,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein I inhibitor,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein II inhibitor,Yes,Categorical (Yes/No)
,,,Distribution,VDss (human),0.124,Numeric (log L/kg)
,,,Distribution,Fraction unbound (human),0.044,Numeric (Fu)
,,,Distribution,BBB permeability,-0.521,Numeric (log BB)
,,,Distribution,CNS permeability,-1.677,Numeric (log PS)
,,,Metabolism,CYP2D6 substrate,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 substrate,Yes,Categorical (Yes/No)
,,,Metabolism,CYP1A2 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C19 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C9 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2D6 inhibitior,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 inhibitior,Yes,Categorical (Yes/No)
,,,Excretion,Total Clearance,0.215,Numeric (log ml/min/kg)
,,,Excretion,Renal OCT2 substrate,No,Categorical (Yes/No)
,,,Toxicity,AMES toxicity,Yes,Categorical (Yes/No)
,,,Toxicity,Max. tolerated dose (human),-0.272,Numeric (log mg/kg/day)
,,,Toxicity,hERG I inhibitor,No,Categorical (Yes/No)
,,,Toxicity,hERG II inhibitor,Yes,Categorical (Yes/No)
,,,Toxicity,Oral Rat Acute Toxicity (LD50),2.82,Numeric (mol/kg)
,,,Toxicity,Oral Rat Chronic Toxicity (LOAEL),1.399,Numeric (log mg/kg_bw/day)
,,,Toxicity,Hepatotoxicity,No,Categorical (Yes/No)
,,,Toxicity,Skin Sensitisation,No,Categorical (Yes/No)
,,,Toxicity,T.Pyriformis toxicity,0.707,Numeric (log ug/L)
,,,Toxicity,Minnow toxicity,-1.666,Numeric (log mM)
,,,,,,
,,,,,,
,,,,,,
,,,,,,
,,,Absorption,Water solubility,-5.383,Numeric (log mol/L)
,,,Absorption,Caco2 permeability,0.386,Numeric (log Papp in 10-6 cm/s)
,,,Absorption,Intestinal absorption (human),93.845,Numeric (% Absorbed)
,,,Absorption,Skin Permeability,-2.664,Numeric (log Kp)
,,,Absorption,P-glycoprotein substrate,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein I inhibitor,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein II inhibitor,Yes,Categorical (Yes/No)
,,,Distribution,VDss (human),0.124,Numeric (log L/kg)
,,,Distribution,Fraction unbound (human),0.044,Numeric (Fu)
,,,Distribution,BBB permeability,-0.521,Numeric (log BB)
,,,Distribution,CNS permeability,-1.677,Numeric (log PS)
,,,Metabolism,CYP2D6 substrate,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 substrate,Yes,Categorical (Yes/No)
,,,Metabolism,CYP1A2 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C19 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C9 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2D6 inhibitior,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 inhibitior,Yes,Categorical (Yes/No)
,,,Excretion,Total Clearance,0.215,Numeric (log ml/min/kg)
,,,Excretion,Renal OCT2 substrate,No,Categorical (Yes/No)
,,,Toxicity,AMES toxicity,Yes,Categorical (Yes/No)
,,,Toxicity,Max. tolerated dose (human),-0.272,Numeric (log mg/kg/day)
,,,Toxicity,hERG I inhibitor,No,Categorical (Yes/No)
,,,Toxicity,hERG II inhibitor,Yes,Categorical (Yes/No)
,,,Toxicity,Oral Rat Acute Toxicity (LD50),2.82,Numeric (mol/kg)
,,,Toxicity,Oral Rat Chronic Toxicity (LOAEL),1.399,Numeric (log mg/kg_bw/day)
,,,Toxicity,Hepatotoxicity,No,Categorical (Yes/No)
,,,Toxicity,Skin Sensitisation,No,Categorical (Yes/No)
,,,Toxicity,T.Pyriformis toxicity,0.707,Numeric (log ug/L)
,,,Toxicity,Minnow toxicity,-1.666,Numeric (log mM)
,,,,,,
,,,,,,
,,,,,,
,,,,,,
,,,,,,
,,,Absorption,Water solubility,-5.383,Numeric (log mol/L)
,,,Absorption,Caco2 permeability,0.386,Numeric (log Papp in 10-6 cm/s)
,,,Absorption,Intestinal absorption (human),93.845,Numeric (% Absorbed)
,,,Absorption,Skin Permeability,-2.664,Numeric (log Kp)
,,,Absorption,P-glycoprotein substrate,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein I inhibitor,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein II inhibitor,Yes,Categorical (Yes/No)
,,,Distribution,VDss (human),0.124,Numeric (log L/kg)
,,,Distribution,Fraction unbound (human),0.044,Numeric (Fu)
,,,Distribution,BBB permeability,-0.521,Numeric (log BB)
,,,Distribution,CNS permeability,-1.677,Numeric (log PS)
,,,Metabolism,CYP2D6 substrate,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 substrate,Yes,Categorical (Yes/No)
,,,Metabolism,CYP1A2 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C19 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C9 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2D6 inhibitior,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 inhibitior,Yes,Categorical (Yes/No)
,,,Excretion,Total Clearance,0.215,Numeric (log ml/min/kg)
,,,Excretion,Renal OCT2 substrate,No,Categorical (Yes/No)
,,,Toxicity,AMES toxicity,Yes,Categorical (Yes/No)
,,,Toxicity,Max. tolerated dose (human),-0.272,Numeric (log mg/kg/day)
,,,Toxicity,hERG I inhibitor,No,Categorical (Yes/No)
,,,Toxicity,hERG II inhibitor,Yes,Categorical (Yes/No)
,,,Toxicity,Oral Rat Acute Toxicity (LD50),2.82,Numeric (mol/kg)
,,,Toxicity,Oral Rat Chronic Toxicity (LOAEL),1.399,Numeric (log mg/kg_bw/day)
,,,Toxicity,Hepatotoxicity,No,Categorical (Yes/No)
,,,Toxicity,Skin Sensitisation,No,Categorical (Yes/No)
,,,Toxicity,T.Pyriformis toxicity,0.707,Numeric (log ug/L)
,,,Toxicity,Minnow toxicity,-1.666,Numeric (log mM)
,,,,,,
,,,,,,
,,,,,,
,,,Absorption,Water solubility,-5.383,Numeric (log mol/L)
,,,Absorption,Caco2 permeability,0.386,Numeric (log Papp in 10-6 cm/s)
,,,Absorption,Intestinal absorption (human),93.845,Numeric (% Absorbed)
,,,Absorption,Skin Permeability,-2.664,Numeric (log Kp)
,,,Absorption,P-glycoprotein substrate,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein I inhibitor,Yes,Categorical (Yes/No)
,,,Absorption,P-glycoprotein II inhibitor,Yes,Categorical (Yes/No)
,,,Distribution,VDss (human),0.124,Numeric (log L/kg)
,,,Distribution,Fraction unbound (human),0.044,Numeric (Fu)
,,,Distribution,BBB permeability,-0.521,Numeric (log BB)
,,,Distribution,CNS permeability,-1.677,Numeric (log PS)
,,,Metabolism,CYP2D6 substrate,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 substrate,Yes,Categorical (Yes/No)
,,,Metabolism,CYP1A2 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C19 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2C9 inhibitior,Yes,Categorical (Yes/No)
,,,Metabolism,CYP2D6 inhibitior,No,Categorical (Yes/No)
,,,Metabolism,CYP3A4 inhibitior,Yes,Categorical (Yes/No)
,,,Excretion,Total Clearance,0.215,Numeric (log ml/min/kg)
,,,Excretion,Renal OCT2 substrate,No,Categorical (Yes/No)
,,,Toxicity,AMES toxicity,Yes,Categorical (Yes/No)
,,,Toxicity,Max. tolerated dose (human),-0.272,Numeric (log mg/kg/day)
,,,Toxicity,hERG I inhibitor,No,Categorical (Yes/No)
,,,Toxicity,hERG II inhibitor,Yes,Categorical (Yes/No)
,,,Toxicity,Oral Rat Acute Toxicity (LD50),2.82,Numeric (mol/kg)
,,,Toxicity,Oral Rat Chronic Toxicity (LOAEL),1.399,Numeric (log mg/kg_bw/day)
,,,Toxicity,Hepatotoxicity,No,Categorical (Yes/No)
,,,Toxicity,Skin Sensitisation,No,Categorical (Yes/No)
,,,Toxicity,T.Pyriformis toxicity,0.707,Numeric (log ug/L)
,,,Toxicity,Minnow toxicity,-1.666,Numeric (log mM)